why choose us

First received: April 29, 2024

Clinical Trial: Effect of Erythromycin on the Absorption, Metabolism and Elimination of CHF6001 in Healthy Volunteers

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Chronic Obstructive Pulmonary Disease

Study Type: INTERVENTIONAL


Official Title: Open-label, Non-randomised, One-sequence Crossover Study to Investigate the Effect of Inhibition of CYP3A4/5 by Erythromycin on the Pharmacokinetics of CHF6001 in Healthy Subjects

Brief Summary: The objective of this study is to investigate the effect of the interaction of Erythromycin (CYP3A4/5 moderate inhibitor) on the pharmacokinetic of CHF6001 (CYP3A4/5 substrate) in Healthy Volunteers.

Read more